Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation.

@article{Armbruster2015SafetyON,
  title={Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation.},
  author={Heather L Armbruster and John P Lindsley and Michael P Moranville and Mohammadali Habibi and Irfan M. Khurram and David D Spragg and Ronald D. Berger and Hugh Calkins and Joseph Edward Marine},
  journal={The Annals of pharmacotherapy},
  year={2015},
  volume={49 3},
  pages={278-84}
}
BACKGROUND The novel oral anticoagulants (NOACs) are used for stroke prevention in atrial fibrillation (AF), but their safety and efficacy in the periablation period are not well established. Additionally, no standard procedure for managing periprocedural and intraprocedural anticoagulation has been established. OBJECTIVE To evaluate the frequency of hemorrhagic and thrombotic events as well as periprocedural management strategies of NOACs compared with warfarin as anticoagulation therapy for… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 14 times over the past 90 days. VIEW TWEETS